Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07025720 · ClinicalTrials.gov registry record · NA

Accelerated Intermittent Theta Burst Stimulation for Adolescent and Young Adult Depression With Elevated Suicide Risk

A NA study of Suicidal Ideation and Major Depressive Disorder (MDD), sponsored by University of California, Davis.

Recruiting
Registry status
NA
Development phase
25
Enrollment target
1
Study location

NCT07025720 is a NA study of Suicidal Ideation and Major Depressive Disorder (MDD) that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 25 participants, below the 268-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07025720, a NA study of Suicidal Ideation and Major Depressive Disorder (MDD), is actively recruiting participants, sponsored by University of California, Davis.

RECRUITING
Registry status
NA
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to learn if a fast-acting brain stimulation treatment called transcranial magnetic stimulation (TMS) can help people with depression and suicidal thoughts. The treatment is non-invasive (does not involve surgery or medications), is given over 5 days, and uses brain imaging (MRI) to guide which part of the brain to target. This study tests whether this treatment is a helpful and practical option for adolescents and young adults who are depressed and have suicidal thoughts. We want to see if: 1. This treatment is feasible and acceptable to patients 2. It can reduce depression and suicidal thoughts 3. It can lower the chance of going to the hospital 4. It affects daily functioning (school, work, relationships) All participants will undergo 5-days of TMS treatment and complete MRI brain scans before and after treatment. They will return for check-ups after 1 week and 4 weeks.

Interventions

  • DEVICE TMS

Study Locations (1)

California

  • UC Davis Medical Center - Sacramento

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2025-07-01
Est. Completion 2027-05-31
Phase NA

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT07025720

The ClinicalTrials.gov registry entry for NCT07025720 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 268-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (91% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Suicidal Ideation appearing as the primary indexed condition, and to 1 intervention - of which TMS is the first listed.

NCT07025720 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT07025720 about?

NCT07025720 is a clinical study titled "Accelerated Intermittent Theta Burst Stimulation for Adolescent and Young Adult Depression With Elevated Suicide Risk". The goal of this clinical trial is to learn if a fast-acting brain stimulation treatment called transcranial magnetic stimulation (TMS) can help people with depression and suicidal thoughts. The treatment is non-invasive (does not involve surgery or medications), is given over 5 days, and uses brain...

What is the current status of trial NCT07025720?

This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2025-07-01. Estimated completion is 2027-05-31.

What conditions does trial NCT07025720 study?

This clinical trial studies the following conditions: Suicidal Ideation, Major Depressive Disorder (MDD).

What interventions are being tested in trial NCT07025720?

The interventions under investigation include: TMS (DEVICE).

Who is sponsoring clinical trial NCT07025720?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07025720 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicidal Ideation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.